South Bay Examiner
  • Local news
  • News
  • Business
  • Education
  • Elections
  • Opinion
  • Sports
  • Things to Do
Facebook Twitter Instagram
Facebook Twitter Instagram
South Bay Examiner
Button
  • Local news
  • News
  • Business
  • Education
  • Elections
  • Opinion
  • Sports
  • Things to Do
South Bay Examiner
Home » Alliance for Pharmacy Compounding responds to Hims & Hers Super Bowl Ad

Alliance for Pharmacy Compounding responds to Hims & Hers Super Bowl Ad

0
By admin on February 7, 2025 Business, Lifestyle
Share
Facebook Twitter LinkedIn Pinterest Email

The Hims & Hers planned Super Bowl ad buy – and the content of that ad – is noteworthy, but not because it violates any regulations. 

Indeed, the ad generally complies with federal law and U.S. Food and Drug Administration guidance, as well as the Alliance for Pharmacy Compounding’s recommended Best Practices for Marketing Claims related to compounded drugs. 

I say more about that below. Still, it’s being pronounced in media stories as misrepresentative, and one even refers to it, incredibly, as ‘the Wild West.” It is neither. Yet as a result, U.S. Senators Richard Durbin and Roger Marshall have written to FDA to say the ad “risks misleading patients by omitting any safety or side effect information” and suggest that the agency “take enforcement action against marketing that may mislead patients about this company’s products.” It’s a perplexing request, considering that drugmakers run this sort of service-focused, disclosure free advertising all the time. Because there appears to be confusion about the nature of the ad, the role of compounded drugs, and what regulatory standards apply to their advertising and labeling, here is a primer. 

Compounded drugs are not FDA-approved and are not subject to large-scale clinical trials 

Unlike FDA-approved drugs, compounded medications do not go through large-scale, double-blind, placebo-controlled clinical trials to establish their safety and efficacy. Instead, these medications are prepared by state-licensed compounding pharmacies or FDA-registered outsourcing facilities to meet specific patient needs when commercially available options are unavailable or unsuitable. Because compounded medications are not FDA-approved, they do not carry standardized FDArequired labeling, including side-effect warnings, boxed warnings, or risk evaluation and mitigation strategies (REMS) that apply to approved drugs. However, they are still subject to state board of pharmacy oversight and must comply with USP compounding standards and Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Unlike FDA-approved drugs, which must comply with strict labeling requirements under the Federal Food, Drug, and Cosmetic Act, compounded medications have different rules for marketing and advertising. Labeling applies to the physical drug container and ancillary written materials (like package inserts) and includes required information for prescribers and patients. In contrast, marketing materials and advertisements must follow separate regulations overseen by the FDA and the Federal Trade Commission (FTC). 

Who regulates these advertisements? 

• The FDA regulates advertising for FDA-approved drugs, ensuring that prescription drug ads are truthful, balanced, and not misleading. 

• The FTC regulates advertising for non-FDA-approved products, including compounded drugs and dietary supplements. 

The FTC’s focus is on preventing false or deceptive advertising and ensuring that promotional materials accurately describe the product without misleading claims. This distinction is important because compounded drug advertisements fall under FTC jurisdiction, not the FDA’s typical prescription drug advertising rules. 

APC’s Best Practices for Marketing Compounded Drugs 

The Alliance for Pharmacy Compounding has established Best Practices for Marketing Compounded Drugs to guide pharmacies in providing accurate and transparent communications to patients and prescribers. 

One key recommendation is that marketing materials for compounded drugs should include a disclosure that the product is not FDA-approved. This helps ensure patients and healthcare providers understand the regulatory distinction between compounded and manufactured medications. 

The Hims ad is consistent with “help-seeking” pharmaceutical advertising 

Because the Hims ad does not promote a specific drug or medication, it is not required to provide information about side effects or risks. 

Many FDA-approved drug manufacturers produce similar “help-seeking” advertisements, which do not name a specific drug but instead educate patients about a medical condition and encourage them to consult a healthcare provider. These ads avoid direct claims about a particular drug’s benefits or risks, making them different from direct-to-consumer drug advertisements, which must include risk disclosures. 

Here are examples: 

• Eli Lilly Disrupts Grammys With a Timely Message About Breast Cancer 

• Eli Lilly TV Spot, ‘Alzheimer’s Disease: Hope’ 

• My Time to Quit Smoking Commercial – Pfizer (2007)

Share this:

  • Post

Like this:

Like Loading...
Alliance for Pharmacy Compounding Hims & Hers Super Bowl Ad
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

California’s Fast Food Minimum Wage Increase Has Led to Higher Food Prices and Job Losses  

February 18, 2025

Women Raise the Game Honors Powerhouse Women in Sports During the Big Game Weekend

February 12, 2025

Pepsi® kicks off iconic Pepsi Challenge with Pepsi Zero Sugar during Super Bowl weekend

February 6, 2025

Leave A Reply Cancel Reply

Arts & Culture

Latino Theater Company celebrates 40 yearsof theater and community with ambitious 2025 season

March 1, 2025

Review: ‘Alabaster’

February 25, 2025

PJ Morton, Will Downing to headline Dymally International Jazz & Arts Festival April 26

February 6, 2025

Echo Theater Company has another exciting season of offbeat plays in store for L.A. audiences 

January 25, 2025
Entertainment

Evolving on My Own Terms: Embracing My Journey as an Artist, Entrepreneur, Innovator, and Creator

February 24, 2025

FireAid Concert On-Demand for a Year, Steve Ballmer will Continue to Match Donations

February 7, 2025

Hasbro Enhances the MONOPOLY Play Experience With Evolution of the Classic Game and New Ways to Play

January 7, 2025

Lil Wayne, Chris Brown and Marshmello Allegedly Misused Pandemic Grants to Pay Themselves or Throw Lavish Parties

December 18, 2024
Real Estate

Apartments being converted from office buildings reaches record high

February 18, 2025

East L.A. rental market is heating up!

July 22, 2024
Travel

SPIRIT AIRLINES CARRY-ON FEE CLASS ACTION SETTLEMENT: CLAIM SUBMISSION NOW OPEN

November 14, 2023

Auburn University’s The Laurel Hotel & Spa receives coveted AAA Five Diamond Award for 2023

November 10, 2023

Amtrak Pacific Surfliner offering special service to San Diego

July 13, 2023

Things to Do: Bahamas is the perfect destination for your summer vacation!

July 3, 2023
Lifestyle

Alliance for Pharmacy Compounding responds to Hims & Hers Super Bowl Ad

February 7, 2025

Pepsi® kicks off iconic Pepsi Challenge with Pepsi Zero Sugar during Super Bowl weekend

February 6, 2025

Tribal Casinos initiate suit against California Cardrooms under special interest legislation SB 549

January 3, 2025

Green Label RX opens social-equity cannabis store in Canoga Park

August 21, 2024
Facebook Twitter Instagram
  • Contact
  • DMCA
  • Privacy Policy
  • Terms of Use
© 2025 South Bay Examiner | Site by The Web Lab

Type above and press Enter to search. Press Esc to cancel.

%d